386 related articles for article (PubMed ID: 25645973)
1. Novel therapeutic targets in primary biliary cirrhosis.
Dyson JK; Hirschfield GM; Adams DH; Beuers U; Mann DA; Lindor KD; Jones DE
Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):147-58. PubMed ID: 25645973
[TBL] [Abstract][Full Text] [Related]
2. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
3. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
4. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
5. From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.
Ronca V; Carbone M; Bernuzzi F; Malinverno F; Mousa HS; Gershwin ME; Invernizzi P
Expert Rev Clin Immunol; 2017 Dec; 13(12):1121-1131. PubMed ID: 28994348
[TBL] [Abstract][Full Text] [Related]
6. Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid.
Parés A
Dig Dis; 2015; 33 Suppl 2():125-33. PubMed ID: 26642350
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cirrhosis: therapeutic advances.
Czul F; Peyton A; Levy C
Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
[TBL] [Abstract][Full Text] [Related]
8. Drug Therapies for Chronic Cholestatic Liver Diseases.
Wagner M; Fickert P
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():503-527. PubMed ID: 31506007
[TBL] [Abstract][Full Text] [Related]
9. Primary biliary cirrhosis and bile acids.
Corpechot C
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Mayo MJ
Hepatology; 2022 Aug; 76(2):518-531. PubMed ID: 35152430
[TBL] [Abstract][Full Text] [Related]
12. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid for primary biliary cirrhosis.
Gluud C; Christensen E
Cochrane Database Syst Rev; 2002; (1):CD000551. PubMed ID: 11869580
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
15. [The influence of ursodeoxycholic acid on some biochemical, immunologic and histopathologic parameters in patients with primary biliary cirrhosis].
Skulina D; Owczarek D; Ciećko-Michalska I; Szczepański W; Tetnowski J; Garlicka M; Janas-Skulina U
Przegl Lek; 1999; 56(3):201-4. PubMed ID: 10442009
[TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
17. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
18. [PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA].
Abu Backer F; Abu Mouch S; Mari A
Harefuah; 2018 Dec; 157(12):791-796. PubMed ID: 30582314
[TBL] [Abstract][Full Text] [Related]
19. An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis.
Neuman MG; Cameron RG; Haber JA; Katz GG; Blendis LM
Liver; 2002 Jun; 22(3):235-44. PubMed ID: 12100574
[TBL] [Abstract][Full Text] [Related]
20. Review of Medical Management of Primary Biliary Cholangitis.
Rajendiran G; Mankongpaisarnrung C; Olivera-Martinez MA; McCashland TM
S D Med; 2021 Dec; 74(12):562-568. PubMed ID: 35015947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
